High leptin and resistin expression in chronic heart failure: adverse outcome in patients with dilated and inflammatory cardiomyopathy

2012 ◽  
Vol 14 (11) ◽  
pp. 1265-1275 ◽  
Author(s):  
Peter Bobbert ◽  
Alexander Jenke ◽  
Thomas Bobbert ◽  
Uwe Kühl ◽  
Ursula Rauch ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Adverse Outcome ◽  
Inflammatory Cardiomyopathy

Cardiac extracellular matrix is associated with adverse outcome in patients with chronic heart failure

2016 ◽  
Vol 19 (4) ◽  
pp. 502-511 ◽  
Author(s):  
Franz Duca ◽  
Caroline Zotter-Tufaro ◽  
Andreas A. Kammerlander ◽  
Adelheid Panzenböck ◽  
Stefan Aschauer ◽  
...  
Keyword(s):  
Heart Failure ◽  
Extracellular Matrix ◽  
Chronic Heart Failure ◽  
Adverse Outcome

scholarly journals Biomarkers and the prediction of adverse outcomes in patients with acute decompensated heart failure and kidney injury

2021 ◽  
Vol 10 (3) ◽  
pp. 65-71
Author(s):  
S. L. Glizer ◽  
O. A. Shtegman ◽  
M. M. Petrova
Keyword(s):  
Heart Failure ◽  
Renal Function ◽  
Chronic Heart Failure ◽  
Adverse Outcome ◽  
Acute Decompensated Heart Failure ◽  
Kidney Injury ◽  
Decompensated Heart Failure ◽  
Adverse Outcomes ◽  
Global Burden ◽  
Modern Treatment

Abstract. Chronic heart failure is one of the main contributors to the Global Burden of Cardiovascular Diseases. Despite advances in modern treatment, acute decompensated heart failure (ADHF) incidence is high. Moreover, patients admitted for ADHF encounter renal impairment, which is another predictor of adverse outcome. There are number of biomarkers that allow clinicians to assess the prognosis of the disease in the early stages. The article presents an overview of contemporary biomarkers (utilizing multimarker approach), and identifies the most significant biological markers for evaluating ADHF and worsening renal function.

scholarly journals Inflammatory cytokines in chronic heart failure: interleukin-8 is associated with adverse outcome. Results from CORONA

2013 ◽  
Vol 16 (1) ◽  
pp. 68-75 ◽  
Author(s):  
Ståle H. Nymo ◽  
Johannes Hulthe ◽  
Thor Ueland ◽  
John McMurray ◽  
John Wikstrand ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Inflammatory Cytokines ◽  
Adverse Outcome ◽  
Interleukin 8

scholarly journals Fluid Management In Patients With Chronic Heart Failure

2015 ◽  
Vol 1 (2) ◽  
pp. 90 ◽  
Author(s):  
Pierpaolo Pellicori ◽  
Kuldeep Kaur ◽  
Andrew L Clark ◽  
◽  
◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Fluid Overload ◽  
Adverse Outcome ◽  
Fluid Management ◽  
Objective Measures ◽  
Clinical Feature ◽  
Robust Method ◽  
Randomised Trials ◽  
Heart Failure Patients

Congestion, or fluid overload, is a classic clinical feature of patients presenting with heart failure patients, and its presence is associated with adverse outcome. However, congestion is not always clinically evident, and more objective measures of congestion than simple clinical examination may be helpful. Although diuretics are the mainstay of treatment for congestion, no randomised trials have shown the effects of diuretics on mortality in chronic heart failure patients. Furthermore, appropriate titration of diuretics in this population is unclear. Research is required to determine whether a robust method of detecting — and then treating — subclinical congestion improves outcomes.

Sign in / Sign up

Export Citation Format

Share Document